Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Assets (2017 - 2021)

Historic Other Non-Current Assets for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $2.0 million.

  • Cogent Biosciences' Other Non-Current Assets rose 6223.11% to $2.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 million, marking a year-over-year increase of 6223.11%. This contributed to the annual value of $1.3 million for FY2020, which is 0.0% changed from last year.
  • Per Cogent Biosciences' latest filing, its Other Non-Current Assets stood at $2.0 million for Q3 2021, which was up 6223.11% from $2.0 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Other Non-Current Assets registered a high of $2.6 million during Q1 2018, and its lowest value of $1.3 million during Q2 2018.
  • Over the past 5 years, Cogent Biosciences' median Other Non-Current Assets value was $1.3 million (recorded in 2018), while the average stood at $1.4 million.
  • In the last 5 years, Cogent Biosciences' Other Non-Current Assets tumbled by 5195.25% in 2019 and then surged by 6223.11% in 2021.
  • Over the past 5 years, Cogent Biosciences' Other Non-Current Assets (Quarter) stood at $1.4 million in 2017, then decreased by 8.59% to $1.3 million in 2018, then changed by 0.0% to $1.3 million in 2019, then changed by 0.0% to $1.3 million in 2020, then skyrocketed by 62.23% to $2.0 million in 2021.
  • Its Other Non-Current Assets stands at $2.0 million for Q3 2021, versus $2.0 million for Q2 2021 and $1.3 million for Q1 2021.